Screener
Axsome Therapeutics AXSM Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Axsome Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Axsome Therapeutics’s 10-Q, filed May 4, 2026.
- Filed
- May 4, 2026, 5:04 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-204274
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Prepaid and other current assets | 23,523 | 13,651 |
| Total current assets | 611,206 | 588,986 |
| Equipment, net | 567 | 562 |
| Right-of-use asset - operating lease | 20,014 | 20,858 |
| Goodwill | 12,042 | 12,042 |
| Intangible asset, net | 38,947 | 40,519 |
| Non-current inventory and other assets | 30,831 | 26,838 |
| Total assets | $713,607 | $689,805 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Axsome Therapeutics's operating lease ROU assets?
- Axsome Therapeutics (AXSM) reported operating lease ROU assets of $20.01M in Q1 2026.
- How has Axsome Therapeutics's operating lease ROU assets changed year-over-year?
- Axsome Therapeutics's operating lease ROU assets decreased by 14.1% year-over-year, from $23.29M to $20.01M.
- What is the long-term trend for Axsome Therapeutics's operating lease ROU assets?
- Over 5 years (2020 to 2025), Axsome Therapeutics's operating lease ROU assets has grown at a 64.4% compound annual growth rate (CAGR), from $1.74M to $20.86M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Axsome Therapeutics's operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude